Nextpharma Technologies Holding Ltd
Nextpharma Technologies Holding Ltd
09/09/2026 | Press release | Archived content
NextPharma Tampere Warehouse Achieves Operational Approval
NextPharma Tampere Warehouse Achieves Operational Approval
NextPharma has announced official operational approval for its state-of-the-art Main Warehouse facility at its Tampere, Finland site. The milestone represents a significant expansion in warehouse capacity and reinforces the company's strategic growth trajectory in the contract development and manufacturing organisation (CDMO) sector.
- Tampere
- 09/09/2026
- 3 min read
Share
NextPharma's newly approved warehouse facility at its Tampere Centre of Excellence delivers transformational storage capacity and operational capabilities. The facility combines advanced temperature control, modernised digital systems, and scalable infrastructure to support the company's growing customer base.
The facility includes:
- 4,410 total pallet positions
- 1,740 pallets of cold storage at 2-8°C
- 2,670 pallets for finished goods and raw materials at 20-25°C
- Continuous temperature monitoring and control systems
Beyond increased capacity, the warehouse represents a strategic technology upgrade. NextPharma has integrated advanced digital warehouse management tools and modernised SAP processes through its SAP Renew project, enhancing operational efficiency and scalability. These improvements position the Tampere site to support NextPharma's expansion as a specialised CDMO hub for ophthalmic products.
"Averline needed a partner able to take two products from registration batches to global supply without a change of site. That continuity is exactly what our Tampere Centre of Excellence was built for."
Ajeeth Enjeti · Chief Executive Officer, NextPharma
The warehouse expansion is expected to significantly increase capacity for meeting client demand across NextPharma's ophthalmic and broader CDMO portfolio. The facility operationalisation is the first phase in a broader transformation of the Tampere site into a major CDMO hub.
About NextPharma
NextPharma is a European contract development and manufacturing organisation offering pharmaceutical development, clinical trials services, commercial manufacturing and packaging, and analytical and microbiological services. The group operates eleven sites across the United Kingdom, Germany, France, Finland and Norway, all running on renewable electricity.
Download
This press release as PDF
Full text and boilerplate, ready for publication · PDF, 240 KB, EN
Topics in this article
Nextpharma Technologies Holding Ltd published this content on September 09, 2026, and is solely responsible for the information contained herein. Distributed via Public Technologies (PUBT), unedited and unaltered, on October 15, 2026 at 14:05 UTC. If you believe the information included in the content is inaccurate or outdated and requires editing or removal, please contact us at [email protected]